Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sue J. Kohlhepp"'
Multicenter Evaluation of a New Screening Test That Detects Clostridium difficile in Fecal Specimens
Autor:
Limin Zheng, David M. Lyerly, K. Ye, Curt A. Gleaves, S. Perez, C. W. Genheimer, Stephen Young, Sue J. Kohlhepp, S. F. Keller, Robert J. Carman
Publikováno v:
Journal of Clinical Microbiology. 42:3837-3840
Clostridium difficile causes approximately 25% of nosocomial antibiotic-associated diarrheas and most cases of pseudomembranous colitis. We evaluated C. DIFF CHEK , a new screening test that detects glutamate dehydrogenase of C. difficile . Our resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e341a370c693cb4c9d20b0d53dfbbcb8
https://doi.org/10.1128/jcm.42.8.3837-3840.2004
https://doi.org/10.1128/jcm.42.8.3837-3840.2004
Publikováno v:
Journal of Chromatography B. 773:159-166
We attempted to devise a preparation method for clinical samples that could be used for all antibiotics and antivirals. We studied thirteen antibiotics, including five penicillins, four cephalosporins, metronidazole, ofloxacin, and sulfamethoxazole a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd3e26e363881850ba5501cd9f40b8c7
https://doi.org/10.1016/s1570-0232(02)00140-x
https://doi.org/10.1016/s1570-0232(02)00140-x
Autor:
James Leggett, G. Lewis, David N. Gilbert, R. J. Dworkin, K. A. Slama, G. Grunkemeier, S. E. Slaughter, Sue J. Kohlhepp
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:883-892
The phenotypic resistance of selected organisms to ciprofloxacin, levofloxacin, and trovafloxacin was defined as a MIC of ≥4 μg/ml. The dynamics of resistance were studied after single and sequential drug exposures: clinical isolates of methicilli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2deb5b7bf44e4c29cf60b5294483f7c9
https://doi.org/10.1128/aac.45.3.883-892.2001
https://doi.org/10.1128/aac.45.3.883-892.2001
Autor:
Sarah Klizas West, Sue J. Kohlhepp, Walter E. Stamm, Ruyun Jin, David N. Gilbert, Curt A. Gleaves
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 48(5)
BACKGROUND: There is a long history of research suggesting that Chlamydophila pneumoniae is associated with coronary artery disease (CAD). C. pneumoniae in peripheral blood mononuclear cells (PBMCs) could serve as a risk factor for CAD if respiratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6805e0d76c4315fbe187bc427edff6
https://pubmed.ncbi.nlm.nih.gov/19191640
https://pubmed.ncbi.nlm.nih.gov/19191640
Autor:
Robert Gresbrink, Curt A. Gleaves, Paul Metz, Sue J. Kohlhepp, David N. Gilbert, J. Stone Doggett
The incidence of Lyme disease in Oregon is calculated from cases reported to the Oregon State Health Division. We reviewed the exposure history of reported cases of Lyme disease and performed field surveys for infected Ixodes pacificus ticks. The inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50290137b6d48beaf53c6e853542f09e
https://europepmc.org/articles/PMC2446842/
https://europepmc.org/articles/PMC2446842/
Serological studies of Chlamydia pneumoniae in humans have shown a correlation between the age of a population and the number of individuals positive for C. pneumoniae antibodies. Grayston ([1][1]) has reported that individuals younger than 30 had 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e569aa47c0f8713e857e3717897c77c
https://europepmc.org/articles/PMC1151879/
https://europepmc.org/articles/PMC1151879/
Publikováno v:
Diagnostic cytopathology. 26(4)
Two techniques have been approved by the United States FDA for diagnosis of tuberculosis in smear positive sputa: LCX M. tuberculosis, a ligase chain reaction procedure manufactured by Abbott Laboratories, and Amplicor, a polymerase chain reaction (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9a21f49f5940b486135eb148c8eb063
https://pubmed.ncbi.nlm.nih.gov/11933274
https://pubmed.ncbi.nlm.nih.gov/11933274
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 33(4)
Meropenem is a carbapenem antibiotic with a broad antibacterial spectrum of activity. Its main route of elimination is through the kidneys, with 63% of the drug excreted unchanged in the urine. Meropenem clearance is diminished in renal impairment; t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c3a7670860fedc2d0e7bb6dcf7c09e
https://pubmed.ncbi.nlm.nih.gov/10196026
https://pubmed.ncbi.nlm.nih.gov/10196026
The influence of assay methodology on the measurement of the active free fraction of ceftriaxone in plasma was determined. The free fraction was measured by three methods: agar diffusion bioassay, precipitation of plasma protein with methanol followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414bec13c03830abafff564a6d7d1340
https://europepmc.org/articles/PMC105804/
https://europepmc.org/articles/PMC105804/
Autor:
Sue J. Kohlhepp, David N. Gilbert, George A. Porter, Paul W. Kohnen, Craig A. Wood, Donald C. Houghton, Robert E. Brummett, William M. Bennett, Debra R. Norton
Publikováno v:
Journal of Infectious Diseases. 158:13-22
The influence of dosage regimen on the nephrotoxicity, ototoxicity, and antibacterial efficacy of tobramycin was assessed in Fisher rats with Pseudomonas aeruginosa subcutaneous abscesses. A subcutaneous tobramycin dose of 10 mg/kg every 4 h resulted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::585b937981f9fb58474bc1a0d8acafe8
https://doi.org/10.1093/infdis/158.1.13
https://doi.org/10.1093/infdis/158.1.13